News
In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback